Michael Benkowitz is President & COO at UNITED THERAPEUTICS Corp (UTHR). They have made 11 open-market trades across 1 company since 2022, most recently 2026-03-15.
CIK 0001673232
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 19,046 | $10.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL | 2026-02-23 | 2026-02-24 | $472.13 | $6.8M | -0.4% | +10.9% | +20.5% |
| UTHR | SELL | 2026-02-17 | 2026-02-18 | $480.75 | $10.8M | +7.7% | +9.8% | +18.8% |
| UTHR | SELL | 2026-02-09 | 2026-02-10 | $474.65 | $10.7M | -0.0% | +12.3% | +20.1% |
| UTHR | SELL | 2026-02-02 | 2026-02-03 | $470.95 | $10.6M | -1.7% | +0.6% | +20.6% |
| UTHR | SELL | 2026-01-20 | 2026-01-28 | $470.03 | $14.3M | +1.4% | +8.0% | +22.0% |
| UTHR | SELL | 2026-01-20 | 2026-01-28 | $464.66 | $6.8M | +1.4% | +8.0% | +22.0% |
| UTHR | SELL | 2026-01-12 | 2026-01-13 | $479.51 | $10.8M | -0.7% | -0.1% | +21.2% |
| UTHR | SELL | 2026-01-05 | 2026-01-07 | $487.38 | $7.1M | -7.1% | -3.7% | +12.3% |
| UTHR | SELL · 10b5-1 | 2026-01-05 | 2026-01-07 | $487.37 | $3.8M | -7.1% | -3.7% | +12.3% |
| UTHR | SELL · 10b5-1 | 2025-12-29 | 2025-12-30 | $502.79 | $22.6M | -2.6% | -5.5% | +18.8% |
| UTHR | SELL · 10b5-1 | 2025-12-22 | 2025-12-29 | $514.32 | $22.9M | -3.9% | -7.1% | +17.0% |
| UTHR | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $496.49 | $21.1M | +0.6% | -5.6% | +6.8% |
| UTHR | SELL · 10b5-1 | 2025-12-08 | 2025-12-09 | $478.58 | $21.5M | +7.8% | +2.3% | +10.3% |
| UTHR | SELL · 10b5-1 | 2025-12-01 | 2025-12-02 | $479.92 | $21.6M | +4.2% | +4.8% | +8.4% |
| UTHR | SELL · 10b5-1 | 2025-11-24 | 2025-11-26 | $473.66 | $15.6M | -2.8% | +3.4% | -3.4% |
| UTHR | SELL · 10b5-1 | 2025-11-17 | 2025-11-18 | $470.43 | $21.2M | +1.3% | +7.0% | +1.8% |
| UTHR | SELL · 10b5-1 | 2025-11-10 | 2025-11-12 | $452.08 | $16.8M | +4.4% | +8.0% | +3.5% |
| UTHR | SELL · 10b5-1 | 2025-11-03 | 2025-11-04 | $429.08 | $18.9M | +7.8% | +11.9% | +9.8% |
| UTHR | SELL · 10b5-1 | 2025-10-27 | 2025-10-28 | $417.50 | $18.8M | +8.1% | +17.0% | +14.0% |
| UTHR | SELL · 10b5-1 | 2025-10-20 | 2025-10-21 | $427.41 | $19.2M | +5.4% | +12.3% | +10.8% |
| UTHR | SELL · 10b5-1 | 2025-10-13 | 2025-10-15 | $440.35 | $19.8M | -2.1% | +8.4% | +10.9% |
| UTHR | SELL · 10b5-1 | 2025-10-06 | 2025-10-07 | $450.89 | $15.7M | -5.1% | -0.6% | +7.3% |
| UTHR | SELL · 10b5-1 | 2025-09-29 | 2025-10-01 | $421.93 | $17.6M | +1.6% | +2.8% | +14.5% |
| UTHR | SELL · 10b5-1 | 2025-09-22 | 2025-09-24 | $416.35 | $18.7M | +4.3% | -3.7% | +17.4% |
| UTHR | SELL · 10b5-1 | 2025-09-15 | 2025-09-17 | $400.48 | $16.8M | +5.1% | +7.4% | +23.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.